Scroll to top
Tag: digital therapeutics

Game-Based Therapies and The Attraction of Engaging Patients

Article Excerpt: The appeal of developing game-based therapeutics shares many similarities with digital therapeutics in general. Broadly, this means that they can offer great convenience to patients, be more likely to improve adherence, allow for direct feedback to healthcare professionals, and allow patients to be in control of their own health. An added benefit for game-based therapies is that part of the goal in the development process is for the tools to be entertaining, which means that not only can the therapies provide health benefits, but they can also become a welcome part of an individual’s health regime.

Full Article:

Article Source: Pharmaphorum


Digital Therapeutics Should Be Regulated With Gold-Standard Evidence

Article Excerpt: There is enormous growth in the digital health sector, illustrated by huge capital investment, and a massive proliferation of mental and behavioral health apps and associated marketing claims. We are particularly concerned about one component of this sector, namely “software as a medical device”, which the Food and Drug Administration (FDA) defines as “software intended to be used for one or more medical purposes,….without being part of a hardware medical device,” and where the purpose is “treatment or alleviation of disease.” This new approach to treatment, increasingly referred to as digital therapeutics (DTx), has the potential to transform mental health care. The global DTx market was valued at more than $3.5 billion in 2020 and is projected to reach $23.5 billion by 2030. According to industry reporting, the largest number of DTx programs today are related to mental health, and most FDA submissions for DTx use cognitive behavioral therapy to promote behavior change in conditions ranging from insomnia to substance use disorder. The opportunity for innovation is clear. However, there are challenges that must be addressed.

Full Article:

Article Source: Health Affairs


Global Digital Health Funding Skyrockets to $57.2 B with Record Cash for Mental Health, Telehealth

Article Excerpt: Digital therapeutics (DTx) startups secured a record-breaking $3.4 billion across 122 deals in 2021, up 133% from the prior year. DTx enables the treatment of chronic conditions at scale and is demonstrating improved patient outcomes in clinical trials, according to CB Insights analysts. This is driving investor interest in the technology’s future. The digital mental health space was growing rapidly even before the COVID-19 pandemic but stress and anxiety brought on by the health crisis have accelerated demand for virtual behavioral health services, including mobile mental health apps.

Full Article:

Article Source: Fierce Healthcare


FDA Grants Breakthrough Therapy Designation to Device to Treat AML-Induced Depression

Article Excerpt: The FDA has granted a breakthrough device designation to BNT200, a digital therapeutic designed to treat anxiety and depressive symptoms in adults with acute myeloid leukemia (AML) currently hospitalized for a regimen of high-intensity induction chemotherapy, according to a press release by Blue Note Therapeutics. BNT200 is a software that is designed to treat the unique psychological stressors that create anxiety and depressive symptoms in adult patients with AML undergoing high-intensity induction chemotherapy. It is an on-demand digital therapeutic, with content synchronized with high-intensity chemotherapy treatment.

Full Article:

Article Source: Targeted Oncology


The Therapists Using AI to Make Therapy Better

Article Excerpt: Researchers have tried to study talking therapy for years to unlock the secrets of why some therapists get better results than others. It can be as much art as science, based on the experience and gut instinct of qualified therapists. It’s been virtually impossible to fully quantify what works and why—until now… AI is changing that equation. The type of machine learning that carries out automatic translation can quickly analyze vast amounts of language. That gives researchers access to an endless, untapped source of data: the language therapists use. Researchers believe they can use insights from that data to give therapy a long-overdue boost. The result could be that more people get better, and stay better.

Full Article:

Article Source: MIT Technology Review


The Mental Health Crisis Is Growing. Is Technology One Possible Solution?

Article Excerpt: Discussions surrounding mental health have never been more prominent or vital. After a chaotic two years amidst a global pandemic, rising consumer costs, and a fluid global economic climate, people are exhausted. But societal mental health was taking a toll even prior to the Covid-19 coronavirus pandemic. Statistic after statistic has unequivocally illustrated increasing rates of burnout among professionals, mounting discontent with work-life balance, and skyrocketing rates of depression and suicide—all critical aspects contributing to mental health. Unfortunately, although mental health issues have exponentially grown over the past three decades, services to address these needs have not been able to keep up with the demand… Cue digital health and telehealth services, which are being touted as the newest solutions to increase access to mental health services.

Full Article:

Article Source: Forbes


Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

Article Excerpt: Pear Therapeutics, the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its reSET-A™ PDT product candidate designed for the treatment of alcohol use disorder (AUD). reSET-A potentially expands Pear’s addiction franchise, which includes FDA-authorized products to treat substance use disorder (SUD) and opioid use disorder (OUD). This is the second such Breakthrough Device Designation received by Pear, following the designation awarded for reSET-O®, the first ever for a PDT, which was for the treatment of OUD.

Full Article:

Article Source: BioSpace

How Can We Speed Up Adoption Of Digital Therapeutics?

Article Excerpt: It’s clear that the digital therapeutics (DTx) industry has found new ways to harness the unique power of emerging technologies to improve health. The 2021 DTx East conference highlighted both the tremendous progress made in the industry over the past few years as well as the ongoing challenges of moving into the next phase of growth and, ultimately, getting digital therapeutics into more patients’ lives.

Full Article:

Article Source: Med Device Online


A Healthier Community Could Be Just a Click Away

Article Excerpt: It’s no secret that the pandemic exacerbated the need for mental health resources for many of us. Simultaneously, there is a shortage of mental health professionals able to meet true patient demand. In fact, an American Psychological Association analysis estimates that for everyone who needs support to have it, we’d need to add 20,220 more psychologists by 2030, above the baseline estimated need of 101,120 – and those estimates were published in 2018.

Full Article:

Article Source: U.S. News & World Report